Judong Luo

7PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersEpidemiological methodsImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 23, 2023
Immune Checkpoint Inhibitors Serve as the First-Line Treatment for Advanced Head and Neck Cancer.

Yan Huang, Hong Zhou, Guangyong Zhao

|Dec 12, 2022
Immune infiltration could predict the efficacy of short-term radiotherapy in patients with cervical cancer.

Zhiqiang Sun, Xue Liu, Jing Song

|May 20, 2022
M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer.

Xue Liu, Changsheng Ma, Hui Liu

|Apr 01, 2022
KIF26B in the Prognosis and Immune Biomarking of Various Cancers: A Pan-Cancer Study.

Fei Sun, Yingying Lian, Jianlin Wang

Pageof 2